PER 1.23% 8.0¢ percheron therapeutics limited

next ann:initiation of phase iia trial atl1103, page-20

  1. 14,981 Posts.
    lightbulb Created with Sketch. 51
    ANP looks fine to me and I believe that if they get through trials to a successful product then they will more than likely have a market for it

    I also believe that the market cap will be many, many times it's current one when they eventually do, as a lead up to it

    So I'm buying now, because, whilst peaceAKKI has some valid points, I don't think many stack up for me to caution against buying now because the sp wil be elevated by the time we get through approvals, so any downside in sp risk I see as irrelevant as I will already be largely in substantial profit already

    Anyway just the way I see it, be it right or wrong, but there's too many things pointing to this being a big success coupled with the comments I have just made, to turn me off the stock at these levels now

    Just imo of course
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.001(1.23%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.2¢ 8.2¢ 8.0¢ $63.52K 777.8K

Buyers (Bids)

No. Vol. Price($)
2 43377 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 97561 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.